A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+40.84%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$175M
AUM Growth
+$175M
Cap. Flow
-$31.5M
Cap. Flow %
-18.02%
Top 10 Hldgs %
92.73%
Holding
17
New
1
Increased
2
Reduced
1
Closed
1

Top Buys

1
SIEN
Sientra, Inc.
SIEN
$5.48M
2
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
$900K
3
AUPH icon
Aurinia Pharmaceuticals
AUPH
$833K

Top Sells

1
CRSP icon
CRISPR Therapeutics
CRSP
$38.2M
2
DERM
Dermira, Inc.
DERM
$559K

Sector Composition

1 Healthcare 99.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.71B
$72.7M 41.53% 1,237,202 -650,000 -34% -$38.2M
SIEN
2
DELISTED
Sientra, Inc.
SIEN
$48.3M 27.6% 2,480,494 +281,482 +13% +$5.48M
PRTK
3
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$10.6M 6.04% 1,041,131 – –
OBSV
4
DELISTED
ObsEva SA Ordinary Shares
OBSV
$6.66M 3.81% 440,000 – –
ONCT
5
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$5.2M 2.97% 339,174 – –
TARA icon
6
Protara Therapeutics
TARA
$120M
$4.84M 2.77% 2,017,872 – –
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4.28M 2.44% 1,444,445 – –
CBAY
8
DELISTED
Cymabay Therapeutics
CBAY
$3.67M 2.09% 273,417 – –
CHMA
9
DELISTED
Chiasma, Inc. Common Stock
CHMA
$3.12M 1.78% 2,080,595 – –
ADAP
10
Adaptimmune Therapeutics
ADAP
$15.6M
$2.97M 1.69% 250,000 – –
RARE icon
11
Ultragenyx Pharmaceutical
RARE
$2.89B
$2.93M 1.67% 38,100 – –
CLLS
12
Cellectis
CLLS
$258M
$2.83M 1.61% 100,000 – –
AUPH icon
13
Aurinia Pharmaceuticals
AUPH
$1.58B
$2.25M 1.29% 400,434 +148,305 +59% +$833K
OCGN icon
14
Ocugen
OCGN
$319M
$2.2M 1.26% 888,889 – –
IMDZ
15
DELISTED
Immune Design Corp.
IMDZ
$1.62M 0.93% 352,300 – –
AVEO
16
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$900K 0.51% +400,000 New +$900K
DERM
17
DELISTED
Dermira, Inc.
DERM
– – -70,000 Closed -$559K